https://www.live-feeds.com/feed/moderna-stock-hits-a-new-high-as-ceo-says-it-s-more-than-covid-vaccinesContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/moderna-stock-hits-a-new-high-as-ceo-says-it-s-more-than-covid-vaccineshttps://www.live-feeds.com/feed/moderna-stock-hits-a-new-high-as-ceo-says-it-s-more-than-covid-vaccines#u85712Sun, 27 Sep 2026 00:55:17 +0000Moderna stock has hit a new high as the company shifts its focus toward a broader portfolio of mRNA applications. The company is currently on track to be the second best performing S&P 500 stock for September. This growth follows statements from the CEO regarding the company's innovation strategy and the development of cancer vaccines. While the stock trends positively, the company is working to transition from its primary reliance on Covid-19 vaccines to a more diversified healthcare provider.Why it mattersModerna gained global prominence through its rapid development of mRNA Covid-1